WHO ICTRP trial

A Study of RO5072759 (GA101) in Combination With CHOP Chemotherapy Versus…

EUCTR2010-024194-39-GB · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2010-024194-39-GB
Public title A Study of RO5072759 (GA101) in Combination With CHOP Chemotherapy Versus MabThera/Rituxan (Rituximab) With CHOP in Patients With CD20-Positive Diffuse Large B-Cell Lymphoma
Scientific title A PHASE III, MULTICENTER, OPEN-LABEL, RANDOMIZED TRIAL COMPARING THE EFFICACY OF GA101 (RO5072759) IN COMBINATION WITH CHOP (G-CHOP) VERSUS RITUXIMAB AND CHOP (R-CHOP) IN PREVIOUSLY UNTREATED PATIENTS WITH CD20 POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) - GOYA
Primary sponsor F. Hoffmann-La Roche Ltd.
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no
Countries United States;Slovakia;Thailand;Spain;Ukraine;Korea, Democratic People's Republic of;Austria;United Kingdom;Italy;Czech Republic;Hungary;Canada;Poland;Denmark;Australia;Germany;Japan
Conditions PREVIOUSLY UNTREATED PATIENTS WITH CD20-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) MedDRA version: 20.0 Level: HLT Classification code 10012819 Term: Diffuse large B-cell lymphomas System Organ Class: 100000004943 MedDRA version: 20.0…
Interventions Product Name: Obinutuzumab (GA101) Product Code: RO5072759 Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: Obinutuzumab CAS Number: 949142-50-1 Current Sponsor code: RO5072759/F06 Other descriptive name…
Registration date Oct 3, 2011
Target size 1400
Secondary IDs BO21005;NCT01287741;2010-024194-39-ES
Registry page clinicaltrialsregister.eu

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations